The effect of anticoagulant pharmacotherapy on fracture healing

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 7, 2008, Pages 1169-1187

  Lindner, Tobias ^a,b   Cockbain, Andrew J ^a   El Masry, Mohamed A ^a   Katonis, Paul ^c   Tsiridis, Evgenios ^d   Schizas, Constantin ^e   Tsiridis, Eleftherios E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF CRETE   (Greece)

^d Cardio Thoracic Anaesthetic Unit   (Greece)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Anticoagulant therapy; Aspirin; Fondaparinux; Fracture healing; Heparin; LMWH; Low molecular weight heparin; Pentasaccharide; Thromboprophylaxis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ALKALINE PHOSPHATASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; CERTOPARIN; DALTEPARIN; DICOUMAROL; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; OSTEOCALCIN; OSTEOPROTEGERIN; TINZAPARIN; VASCULOTROPIN; WARFARIN; POLYSACCHARIDE;

ANTICOAGULANT THERAPY; BONE CELL; BONE DEFECT; BONE DENSITY; BONE DEVELOPMENT; BONE EROSION; BONE METABOLISM; CALLUS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DOWN REGULATION; DRUG MECHANISM; FRACTURE HEALING; FRACTURE NONUNION; GENE EXPRESSION; HUMAN; HUMAN CELL CULTURE; LOW DRUG DOSE; MEDLINE; MITOGENESIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; THROMBOSIS PREVENTION; TREATMENT DURATION; ANIMAL; BONE; BONE REMODELING; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; METABOLISM;

ANIMALS; ANTICOAGULANTS; ASPIRIN; BONE AND BONES; BONE REMODELING; DISEASE MODELS, ANIMAL; FRACTURE HEALING; HEPARIN; HUMANS; POLYSACCHARIDES; WARFARIN;

EID: 43049172051     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.7.1169     Document Type: Review

References (91)